| 000 | 01561 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516072433.0 | ||
| 264 | 0 | _c20130701 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2011.04436.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIshida, M | |
| 245 | 0 | 0 |
_aCathepsin K expression in basal cell carcinoma. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cJan 2013 |
||
| 300 |
_ae128-30 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 |
_aBowen's Disease _xenzymology |
| 650 | 0 | 4 |
_aCarcinoma, Basal Cell _xenzymology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCathepsin K _xmetabolism |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aKeratosis, Actinic _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xpathology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aSkin Neoplasms _xenzymology |
| 700 | 1 | _aKojima, F | |
| 700 | 1 | _aOkabe, H | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 27 _gno. 1 _gp. e128-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2011.04436.x _zAvailable from publisher's website |
| 999 |
_c21438549 _d21438549 |
||